Canadian health officials have approved the use of silicone gel breast implants, 14 years after the government imposed a partial ban of the product.
Health Canada said it reviewed documents and British and U.S. studies before deciding silicone implants did not cause auto-immune diseases or other systemic illnesses, the Toronto Globe and Mail said. It was these concerns that initially led to the ban.
Licenses granted to Inamed Corp. and Mentor Medical Systems require them to provide data for at least 10 years from a clinical trial, the Globe and Mail said. The manufacturers also must conduct a long-term study of women for possible rare side effects when using the implants.
Plastic surgeons are wondering how much of an impact the new licenses will have, the newspaper said. During the moratorium, women could receive gel-filled implants through a Health Canada program that required doctors to certify suitable alternative procedures weren't available.
The safety of gel implants was questioned when a Canadian study reported a 73 percent higher rate of suicide among women with breast implants than the general population, the Globe and Mail said. In the United States, allegations arose that Mentor misrepresented safety data for its gel breast implants, the report said.
Copyright 2006 by United Press International
Related stories:
Researchers work toward ending cartilage loss
Scientists have long wrestled with how to aid those who suffer cartilage damage and loss. One popular way is to inject an artificial gel that can imitate cartilage's natural ability to act as the body's shock absorber. But that solution is temporary, requiring follow-up injections.
Delayed adverse effects may occur following injection with cosmetic skin fillers
Polyalkylimide implants—injections used as cosmetic fillers primarily in Europe—may be associated with infrequent but sometimes severe immune-related adverse effects months following the procedure, according to a report in the May issue of
Archives of Dermatology.
Freeze-dried tendon implants prove effective in early studies
Donated, freeze-dried tendon grafts loaded with gene therapy may soon offer effective repair of injured tendons, a goal that has eluded surgeons to date. According to study data published today in the journal
Molecular Therapy, a new graft technique may provide the first effective framework around which flexor tendon tissue can reorganize as it heals.
Researchers create system to build transplant tissue
One day soon, laboratories may grow synthetically engineered tissues such as muscle or cartilage needed for transplants. In a major step forward, Cornell engineers describe in the journal
Nature Materials a microvascular system they have developed that can nourish growing tissues.
Dually porous glass shows promise in helping damaged bone regenerate
Victims of osteoporosis and broken bones may get a boost from a new type of biocompatible glass that shows promise in helping damaged and diseased bone to regenerate, says an international team of researchers.
Amazing Gel woes may be 'enormous'
Health officials say more than 500,000 people may have been injected with Amazing Gel, a breast implant material China banned in April, a report said.
Nanomaterials break out of laboratory into marketplace
Miniature medical machines that can bring sight to the blind and computers that work at the speed of light are no longer the stuff of futuristic novels. Argonne National Laboratory researchers are creating
nanomaterials and
nanotechnology to make these and other innovations possible, and collaborating with industry
to bring new technologies to the marketplace.
Researchers design artificial cells that could power medical implants
Researchers at Yale University have created a blueprint for artificial cells that are more powerful and efficient than the natural cells they mimic and could one day be used to power tiny medical implants.